Skip to main content
. 2022 Sep 5;2022:4355182. doi: 10.1155/2022/4355182

Table 2.

PCR primer sequences used in this study.

Target gene Forward primers (5′-3′) Reverse primers (5′-3′) Accession number
zo-1 TGTCAAGTCCCGCAAAAATG CAACTTGCCCTTTGACCTCT XM019260744
zo-2 ACCCGACCTGTTTGTTATTG ATGCCGTGCTTGCTGTC XM 027276911
occludin AGGCTACGGCAACAGTTATG GTGGGTCCACAAAGCAGTAA XM010740442
pcna GAGAGACAAGTGAGAGTTACCG CTCTTTGTCTACATTGCTGGTCT XM 010734227
odc GAGCCAGGTCGCTTCTATG CCGTGGTCCCTTCGTCT XM 010736389
tnf-α ACACCTCTCAGCCACAGGAT CCGTGTCCCACTCCATAGTT NM001303385
il-1β CATAGGGATGGGGACAACGA AGGGGACGGACACAAGGGTA XM010736551
il-6 CGACACACCCACTATTTACAAC TCCCATTTTCTGAACTGCCTCT XM010734753
il-8 AATCTTCGTCGCCTCCATTGT GAGGGATGATCTCCACCTTCG XM010737667.3
il-10 AGTCGGTTACTTTCTGTGGTG TGTATGACGCAATATGGTCTG XM010738826
β-Actin GACCTGACAGACTACCTCATG AGTTGAAGGTGGTCTCGTGGA GU584189

il-1β: interleukin-1β; tnf-α: tumor necrosis factor-α; il-6: interleukin-6; il-8: interleukin-8; il-10: interleukin-10; zo-1: tight junction protein-1; zo-2: tight junction protein-2; pcna: proliferating cell nuclear antigen; odc: ornithine decarboxylase.